» Articles » PMID: 9070288

Protein Phosphorylation Changes Ligand-binding Efficiency of Cytochrome P450c17 (CYP17) and Accelerates Its Proteolytic Degradation: Putative Relevance for Hormonal Regulation of CYP17 Activity

Overview
Publisher Elsevier
Specialty Biochemistry
Date 1997 Feb 13
PMID 9070288
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Two novel mechanisms of protein kinase function in the complex gonadotropic regulation of the bifunctional cytochrome P450c17 (CYP17), the rate-limiting enzyme of androgen synthesis within the smooth endoplasmic reticulum of gonadal endocrine cells, are reported. In microsomal membranes from rat testes, the maximal type I optical difference spectrum induced by the physiological CYP17 substrate, progesterone, as a measure of spin state transition due to hydrophobic ligand-protein interaction is enhanced by 24% within 15 minutes in the presence of MgATP; the dissociation constant decreases from 71 to 43 nM. Testicular cytosol does not modify this effect which is completely abolished by the protein kinase inhibitor, bisindolylmaleimide, and which does not occur with ketoconazole as ligand. Furthermore, CYP17 degradation by cytosolic protease(s) is 2.5-fold accelerated by ATP; this action is completely reversed by the protein kinase inhibitors bisindolylmaleimide (half-maximal protective concentration 2.04 microM) and KT5720 (99 nM). The former compound also prevents human choriogonadotropin-induced testicular CYP17 inactivation in situ. It is concluded that protein kinase A-catalyzed target phosphorylation integrates the known biphasic steroidogenic response upon hormonal stimulation by initial improvement of substrate accommodation followed by counter-regulatory promotion of CYP17 proteolysis.

Citing Articles

Comprehensive History of Genes: Evolution, Phylogenetic Distribution and Functions.

Liu G, Xuan N, Rajashekar B, Arnaud P, Offmann B, Picimbon J Genes (Basel). 2020; 11(4).

PMID: 32290210 PMC: 7230875. DOI: 10.3390/genes11040413.


Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

Wang S, Ekoue D, Raj G, Kittler R Cancer Lett. 2018; 438:86-96.

PMID: 30217566 PMC: 6186492. DOI: 10.1016/j.canlet.2018.09.010.


Functional characterization of the G162R and D216H genetic variants of human CYP17A1.

Capper C, Liu J, McIntosh L, Larios J, Johnson M, Hollenberg P J Steroid Biochem Mol Biol. 2017; 178:159-166.

PMID: 29229304 PMC: 5835412. DOI: 10.1016/j.jsbmb.2017.12.002.


Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame.

Kim S, Wang Y, Nabavi N, Liu Y, Correia M Drug Metab Rev. 2016; 48(3):405-33.

PMID: 27320797 PMC: 5094896. DOI: 10.1080/03602532.2016.1195403.


Hepatic cytochrome P450 ubiquitination: conformational phosphodegrons for E2/E3 recognition?.

Correia M, Wang Y, Kim S, Guan S IUBMB Life. 2014; 66(2):78-88.

PMID: 24488826 PMC: 3959620. DOI: 10.1002/iub.1247.